Are anticholinergics of use in the irritable colon syndrome?
D000328:Adult; D001561:Benzilates / Q000627:therapeutic use; D001565:Benzoates / Q000627:therapeutic use; D003109:Colonic Diseases, Functional / Q000188:drug therapy* / Q000503:physiopathology; D003509:Cyclohexanecarboxylic Acids / Q000627:therapeutic use; D003510:Cyclohexanes / Q000627:therapeutic use; D003967:Diarrhea / Q000188:drug therapy / Q000209:etiology; D004048:Diethylamines / Q000627:therapeutic use; D005260:Female; D005769:Gastrointestinal Motility / Q000187:drug effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D010276:Parasympatholytics / Q000494:pharmacology / Q000627:therapeutic use*; D010627:Phenethylamines / Q000494:pharmacology / Q000627:therapeutic use; D010880:Piperidines / Q000627:therapeutic use; D012601:Scopolamine / Q000494:pharmacology / Q000627:therapeutic use; D012602:Scopolamine Derivatives / Q000627:therapeutic use; D013035:Spasm / Q000188:drug therapy; D013577:Syndrome
D001561:Benzilates; D001565:Benzoates; D003509:Cyclohexanecarboxylic Acids; D003510:Cyclohexanes; D004048:Diethylamines; D010276:Parasympatholytics; D010627:Phenethylamines; D010880:Piperidines; D012602:Scopolamine Derivatives; D012601:Scopolamine